JAMISON REES: Open Payments
NPI 1982231312 · MORGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 40 payments from 13 companies in 2025. Trend: 2023 $498 · 2024 $1,120 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $232 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $67 |
| Indivior Inc. | 2 | $49 |
| PFIZER INC. | 2 | $44 |
| Amgen Inc. | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Exact Sciences Corporation | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, UBRELVY, JARDIANCE, SUBLOCADE, NURTEC ODT, EVENITY, Auvelity.
Industry payments across UT — which companies pay providers there.
